Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Harmer

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Biochemical and Biophysical Research Communications|April 24, 2020
Serine mutation of a conserved threonine in the hERG K<sup>+</sup> channel S6-pore region leads to loss-of-function through trafficking impairmentEhab Al-Moubarak, Yihong Zhang, Christopher E Dempsey, et al.
Respiration; International Review of Thoracic Diseases|May 11, 2004
Pulmonary masses presenting 11 years after abdominal surgeryS Popat, A G Nicholson, C Fisher, et al.
The Biochemical Journal|June 11, 2014
Cellular mechanisms underlying the increased disease severity seen for patients with long QT syndrome caused by compound mutations in KCNQ1Stephen C Harmer, Jagdeep S Mohal, Alice A Royal, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 1, 2023
Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndromeJ C Hancox, C Y Du, A Butler, et al.
Biochemical Pharmacology|August 23, 2025
Noncanonical pharmacological inhibition of the hERG K<sup>+</sup> channel by a synthetic cannabinoidHongwei Cheng, Catherine Upex, Chunyun Du, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1994
The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden HospitalR W Laing, P Hoskin, B V Hudson, et al.
Interface Focus|December 18, 2023
Evaluating pro-arrhythmogenic effects of the T634S-hERG mutation: insights from a simulation studyWei Hu, Wenfeng Zhang, Kevin Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2001
Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid glandC M Nutting, D J Convery, V P Cosgrove, et al.
Frontiers in Cardiovascular Medicine|May 21, 2020
COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2Alexander Carpenter, Owen J Chambers, Aziza El Harchi, et al.
Cellular and Molecular Life Sciences : CMLS|November 2, 2021
Inhibition of the hERG potassium channel by phenanthrene: a polycyclic aromatic hydrocarbon pollutantEhab Al-Moubarak, Holly A Shiels, Yihong Zhang, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Biochemical and Biophysical Research Communications|April 24, 2020
Serine mutation of a conserved threonine in the hERG K<sup>+</sup> channel S6-pore region leads to loss-of-function through trafficking impairmentEhab Al-Moubarak, Yihong Zhang, Christopher E Dempsey, et al.
Respiration; International Review of Thoracic Diseases|May 11, 2004
Pulmonary masses presenting 11 years after abdominal surgeryS Popat, A G Nicholson, C Fisher, et al.
The Biochemical Journal|June 11, 2014
Cellular mechanisms underlying the increased disease severity seen for patients with long QT syndrome caused by compound mutations in KCNQ1Stephen C Harmer, Jagdeep S Mohal, Alice A Royal, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 1, 2023
Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndromeJ C Hancox, C Y Du, A Butler, et al.
Biochemical Pharmacology|August 23, 2025
Noncanonical pharmacological inhibition of the hERG K<sup>+</sup> channel by a synthetic cannabinoidHongwei Cheng, Catherine Upex, Chunyun Du, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1994
The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden HospitalR W Laing, P Hoskin, B V Hudson, et al.
Interface Focus|December 18, 2023
Evaluating pro-arrhythmogenic effects of the T634S-hERG mutation: insights from a simulation studyWei Hu, Wenfeng Zhang, Kevin Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2001
Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid glandC M Nutting, D J Convery, V P Cosgrove, et al.
Frontiers in Cardiovascular Medicine|May 21, 2020
COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2Alexander Carpenter, Owen J Chambers, Aziza El Harchi, et al.
Cellular and Molecular Life Sciences : CMLS|November 2, 2021
Inhibition of the hERG potassium channel by phenanthrene: a polycyclic aromatic hydrocarbon pollutantEhab Al-Moubarak, Holly A Shiels, Yihong Zhang, et al.
Pageof 10